Matthew P. Ottmer
Plus aucun poste en cours
Historique de carrière de Matthew P. Ottmer
Anciens postes connus de Matthew P. Ottmer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur des opérations | 18/09/2017 | 12/02/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur des opérations | 07/12/2015 | 01/04/2017 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1999 | 01/07/2015 |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | President | - | - |
Formation de Matthew P. Ottmer
| University of Michigan | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Operating Officer | 2 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Matthew P. Ottmer
- Expérience
